Debut Plus

₹234.4

▼ -6.41 -2.66%

17 Jul 2026

NSE Listed

Hikal Limited (HIKAL)

Volume: 6,17,604Avg Vol 1W: 10,83,561.8Avg Vol 1M: 10,19,597.7552W Range:₹146.25₹355
NSE BSE www.hikal.com
Key Ratios
Checked 21h ago
Market Cap₹2,969 Cr
Current Price₹234.4
Previous Close₹240.81
High / Low (52w)₹355 / ₹146.25
Volume6,17,604
Avg Vol (1W)10,83,561.8
Avg Vol (1M)10,19,597.75
Stock P/E54.44
Book Value₹102.21
Dividend Yield—
ROE7.4%
ROA—
Revenue (TTM)₹1,865 Cr
Revenue Growth—
Profit Margin—
Total Debt₹367 Cr
Shares Outstanding—
Face Value₹2
EPS (TTM)₹7.35
P/B3.91
Debt / Equity0.65
50 DMA₹209.82
200 DMA₹210.38
Day change-2.66%
Price Chart
₹234.4▼ 32.43% · 1Y
₹352₹1474.5Cr
2025-07-16
2026-07-15

20-day avg volume: 10.2L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 12% YoY.
  • Stock trades at a high P/E of 54.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹407 Cr₹453 Cr₹448 Cr₹552 Cr₹380 Cr₹319 Cr₹494 Cr₹519 Cr
EBITDA₹27 Cr₹44 Cr₹43 Cr₹86 Cr₹-13 Cr₹-32 Cr₹44 Cr₹70 Cr
Net Profit₹5 Cr₹18 Cr₹17 Cr₹50 Cr₹-22 Cr₹-35 Cr₹-6 Cr₹14 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹1,592 Cr₹1,511 Cr₹1,725 Cr₹1,948 Cr₹2,028 Cr₹1,787 Cr₹1,865 Cr₹1,695 Cr
EBITDA₹208 Cr₹194 Cr₹243 Cr₹250 Cr₹153 Cr₹152 Cr₹199 Cr₹0 Cr
Net Profit₹103 Cr₹84 Cr₹133 Cr₹160 Cr₹78 Cr₹70 Cr₹91 Cr₹-49 Cr
EPS8.366.8510.813.026.365.647.36—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹1,686 Cr₹1,768 Cr₹1,913 Cr₹2,213 Cr₹2,385 Cr₹2,487 Cr₹2,529 Cr₹2,365 Cr
Total Liabilities₹929 Cr₹951 Cr₹980 Cr₹1,145 Cr₹1,252 Cr₹1,299 Cr₹1,267 Cr₹1,167 Cr
Equity₹756 Cr₹817 Cr₹933 Cr₹1,068 Cr₹1,133 Cr₹1,188 Cr₹1,262 Cr₹1,199 Cr
Total Debt———————₹684 Cr
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹218 Cr₹325 Cr₹276 Cr₹364 Cr₹344 Cr₹217 Cr₹310 Cr₹302 Cr
Investing₹-125 Cr₹-164 Cr₹-156 Cr₹-284 Cr₹-292 Cr₹-174 Cr₹-136 Cr₹-145 Cr
Financing₹-55 Cr₹-101 Cr₹-97 Cr₹-6 Cr₹-8 Cr₹-27 Cr₹-144 Cr₹-160 Cr
Free Cash Flow₹218 Cr₹325 Cr₹276 Cr₹364 Cr₹344 Cr₹217 Cr₹310 Cr₹154 Cr
Shareholding
Promoter 68.85% Institutions 8.63% Public 22.52%
About Hikal Limited

Pharmaceuticals · Pharmaceuticals - Indian - Bulk Drugs

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

www.hikal.com ↗
Efficiency & Working Capital
ROCE3.6%
Interest Coverage2.7
Dividend Payout—
Debtor Days103 d
Inventory Days66 d
Payable Days60 d
Cash Conversion Cycle108 d
Working Capital Days168 d
Shareholding Details

As of 2026-03-31

Promoter68.9%
FII1.4%
DII7.2%
Institutions8.6%
Public22.5%
Promoter Pledge0%
No. of Shareholders74,270
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters68.9%68.9%68.9%68.9%68.9%68.9%68.9%68.9%68.9%68.9%68.9%68.9%
FIIs4.6%4.8%6.1%6.6%6.7%6.8%6.1%5.7%5.4%4.2%2.3%1.4%
DIIs2.8%3.1%3.2%3.5%3.2%3.6%3.5%3.8%4%5.2%7.1%7.2%
Public23.8%23.2%21.9%21.1%21.3%20.8%21.6%21.7%21.8%21.8%21.8%22.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders75,11076,12674,65771,84070,97871,91271,80168,90771,39173,40474,11774,270
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Kalyani Investment Company LimitedShareholding of Promoter and Promoter Group31.4%3.87 Cr
Castilia Life Sciences Private LimitedShareholding of Promoter and Promoter Group24.5%3.02 Cr
Sugandha J HiremathShareholding of Promoter and Promoter Group7.8%96,67,500
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding3.2%40,00,094
Tata Mutual Fund - Tata Small Cap FundPublic Shareholding2.7%33,00,000
Bf Investment LimitedShareholding of Promoter and Promoter Group2.7%32,73,375
Jai V HiremathShareholding of Promoter and Promoter Group1.1%13,40,625
Pallavi Anish SwadiShareholding of Promoter and Promoter Group0.5%5,68,500
Sameer Jai HiremathShareholding of Promoter and Promoter Group0.3%3,90,975
Sameer TrustShareholding of Promoter and Promoter Group0.2%1,87,500
Ashok Vishwanath HiremathShareholding of Promoter and Promoter Group0.1%1,00,000
Pooja TrustShareholding of Promoter and Promoter Group0.1%75,000
Rhea TrustShareholding of Promoter and Promoter Group0.1%75,000
Nihal TrustShareholding of Promoter and Promoter Group0.1%75,000
Anish TrustShareholding of Promoter and Promoter Group0.1%75,000
Anika TrustShareholding of Promoter and Promoter Group0.1%75,000
Sumer TrustShareholding of Promoter and Promoter Group0.1%75,000
Pooja HiremathShareholding of Promoter and Promoter Group0%7,500
Anish Dilip SwadiShareholding of Promoter and Promoter Group0%7,500
Babasaheb Kalyani Family TrustShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Pooja Hiremath00%2026-03-31
Anish Dilip Swadi00%2026-03-31
Ashok Vishwanath Hiremath00%2026-03-31
Sameer Jai Hiremath00%2026-03-31
Pallavi Anish Swadi00%2026-03-31
Jai V Hiremath00%2026-03-31
Sugandha J Hiremath00%2026-03-31
Pooja Trust00%2026-03-31
Rhea Trust00%2026-03-31
Nihal Trust00%2026-03-31
Anish Trust00%2026-03-31
Anika Trust00%2026-03-31
Board of Directors
NameDesignationYear
J HiremathChairman & Exec. Director2025
Sameer HiremathVice Chairman & M.D.2025
Sugandha HiremathNon Executive Director2025
A B KalyaniNon Executive Director2025
Sarangan SureshWhole-time Director2025
Shivani Bhasin SachdevaIndependent Non Exe. Director2025
Shrikrishna K AdivarekarIndependent Non Exe. Director2025
Berjis DesaiIndependent Non Exe. Director2025
V R KaundinyaIndependent Non Exe. Director2025
Ravi Brijmohan KapoorIndependent Non Exe. Director2025
Ranjana SalgaocarIndependent Non Exe. Director2025
Rajasekhar ReddyCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Crop Protection₹692 Cr37.2%
Pharmaceutical₹1,168 Cr62.8%
Segments — Geography
RegionRevenueShare
India₹704 Cr37.9%
USA and Canada₹251 Cr13.5%
Europe₹530 Cr28.5%
South East Asia₹299 Cr16.1%
Others₹76 Cr4.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2502525
Corporate Actions
TypeDateValueRemark
dividend2026-02-17₹0.2 (10%)Interim
dividend2025-09-02₹0.8 (40%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025800191040
2025000000
2025800191040
Insider / Designated-Person Trades

10 recent disclosure(s)

Castilia Life Sciences LLPAcquisition · 3,02,31,914
Shri Badrinath Investment Private Limited RIPLDisposal · 1,99,78,612
Shri Rameshwara Investment Private Limited RIPLDisposal · 1,02,53,302
Castilia Life Sciences Private LimitedAcquisition · 3,02,31,914
Ashok Vishwanath HiremathAcquisition · 28,540
Ashok Vishwanath HiremathAcquisition · 5,600
Substantial Acquisitions (SAST)

4 disclosure(s)

Others17/02/2026 · 3,02,31,914
Others17/02/2026 · 3,02,31,914
Scheme Of Amalgamation03/12/2025 · 3,02,31,914
Scheme Of Amalgamation03/12/2025 · 3,02,31,914
Company Information
Incorporated1988
ChairmanJ Hiremath
AuditorS R B C & Co LLP
Investor Email[email protected]
🌐 www.hikal.com ↗

📍 717/718 Maker Chamber V, 7th Floor Nariman Point, Mumbai, Maharashtra, 400021

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Hexaware Technologies Ltd.HFCL LimitedH.G.Infra Engineering Ltd.HandsOn Gbl Mngmnt Ltd.Hinduja Global Sols. Ltd.Hi Green Carbon LimitedHighway Infrastructure LimitedHilton Metal Forging Ltd.Himatsingka Seide Ltd.Hindalco Industries Ltd.Hindustan Composites Ltd.Hindcon Chemicals LimitedAll “H” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search